Brainbees Solutions Share Price

FirstCry shares fell on Wednesday after Q4FY26 results showed that margin pressure and high competition offset revenue growth. JM Financial retains Add, with a share price target of 265

• Business Standard
• 3 days 10 hours ago

Internet & Catalogue Retail company Brainbees Solutions announced Q4FY26 & FY26 results Q4FY26 Consolidated Financial Highlights: Revenue from operations stood at Rs 21,626.68 million, representing a decrease of 10.77% on a QoQ basis compared to Rs 24,236.31 million in Q3FY26 and an increase of 12.04% on a YoY basis compared to Rs 19,303.15 million in Q4FY25. Total Income reached Rs 22,034.84 million, showing a decline of 11.17% from Rs 24,804.68 million in Q3FY26 and a growth of 11.36% from Rs 19,787.83 million in the corresponding quarter of the previous year. Loss for the period was Rs 482.07 million, reflecting an increased loss of 25.53% on a QoQ basis compared to Rs 384.04 million in Q3FY26. However, on a YoY basis, the loss narrowed by 56.78% from Rs 1,115.29 million in Q4FY25. Total comprehensive loss for the quarter was Rs 494.73 million, compared to Rs 1,097.35 million in Q4FY25. Basic and Diluted Earnings Per Share (EPS) for the quarter was Rs (0.63). FY26 Consolidated Financial Highlights: Revenue from operations for FY26 grew by 11.60% to Rs 85,479.44 million compared to Rs 76,596.14 million in FY25. Total Income for FY26 was Rs 87,322.53 million, up from Rs 78,100.91 million in the previous year. The annual loss narrowed by 23.09% to Rs 2,036.58 million in FY26 from Rs 2,648.07 million in FY25. Total comprehensive loss for the year was Rs 2,033.28 million, compared to Rs 2,626.51 million in the previous year. Basic and Diluted EPS for the year improved to Rs (2.90) from Rs (4.11) in FY25. Q4FY26 Standalone Financial Highlights: Revenue from operations stood at Rs 6,804.21 million, a decrease of 9.25% on a QoQ basis from Rs 7,497.96 million in Q3FY26 and an increase of 10.45% on a YoY basis from Rs 6,160.33 million in Q4FY25. Total Income for the quarter was Rs 7,210.26 million, a decline of 8.99% QoQ but a growth of 8.55% YoY. Net Profit for the quarter was Rs 316.41 million, down 31.53% from Rs 462.12 million in Q3FY26 and up 111.73% from Rs 149.44 million in Q4FY25. Total comprehensive income for the quarter reached Rs 322.96 million. FY26 Standalone Financial Highlights: Revenue from operations for FY26 reached Rs 27,315.94 million, representing a growth of 10.55% YoY compared to Rs 24,708.56 million in FY25. Annual Net Profit increased by 81.93% to Rs 1,089.30 million from Rs 598.76 million in the previous year. Standalone Basic EPS for FY26 improved to Rs 2.087 from Rs 1.182 in FY25. Business Highlights: Segment Performance: India multi-channel: This segment reported a revenue of Rs 57,533.35 million in FY26 (compared to Rs 52,784.90 million in FY25) and a segment profit of Rs 2,279.31 million. International: This segment reported a revenue of Rs 9,474.18 million in FY26 (compared to Rs 8,585.52 million in FY25) and a segment loss of Rs 1,166.60 million. Globalbees: This segment reported a revenue of Rs 18,943.48 million in FY26 (compared to Rs 15,777.02 million in FY25) and a segment loss of Rs 318.12 million. Investments for Expansion: The Board approved a further investment not exceeding AED 34 million out of IPO proceeds in its wholly owned subsidiary, Firstcry Management DWC LLC. This includes an investment not exceeding SAR 22 million in Firstcry Trading Company, Kingdom of Saudi Arabia, and the balance in Firstcry Retail DWC LLC, United Arab Emirates, for business expansion. Medical Devices Business Transfer: The Company is hiving off its Medical Devices Business to its subsidiary, Morepen Medipath Limited, on a 'slump sale' basis. The 'Appointed Date' has been revised to April 1, 2026. The lump-sum consideration is set at Rs 19,710.12 million, subject to customary adjustments. IPO Proceeds Utilization: As of March 31, 2026, the company has utilized Rs 8,552.35 million from the net IPO proceeds of Rs 16,017.35 million. Major utilizations include sales and marketing initiatives (Rs 1,891.90 million) and funding inorganic growth (Rs 2,706.57 million). Exceptional Items: Consolidated exceptional items (net) for FY26 amounted to an expense of Rs 500.09 million. This primarily includes a loss of Rs 355.71 million from the write-off of current assets in non-core businesses of Globalbees subsidiaries and an impact of Rs 145.21 million on retirement benefits due to the new labour codes. Subsidiary Update: On July 31, 2025, the Parent's shareholding in Dr. Morepen Limited reduced from 80% to 19.94%, resulting in a loss of control. Consequently, it ceased to be a subsidiary and is now accounted for as an investment. Result PDF

• Trendlyne
• 4 days 3 hours ago

Brainbees Solutions shares have surged nearly 22 per cent from the 52-week low of 207.05 touched on February 19, 2026.

• Business Standard
• 2 months 1 week ago